100 related articles for article (PubMed ID: 15642413)
21. Synthesis and anti-tumor activities of a novel series of tricyclic 1-anilino-5H-pyridazino[4,5-b]indoles.
Li RD; Zhai X; Zhao YF; Yu S; Gong P
Arch Pharm (Weinheim); 2007 Aug; 340(8):424-8. PubMed ID: 17628035
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
Marchand P; Antoine M; Le Baut G; Czech M; Baasner S; Günther E
Bioorg Med Chem; 2009 Sep; 17(18):6715-27. PubMed ID: 19682911
[TBL] [Abstract][Full Text] [Related]
23. Arylthioindoles, potent inhibitors of tubulin polymerization.
De Martino G; La Regina G; Coluccia A; Edler MC; Barbera MC; Brancale A; Wilcox E; Hamel E; Artico M; Silvestri R
J Med Chem; 2004 Dec; 47(25):6120-3. PubMed ID: 15566282
[TBL] [Abstract][Full Text] [Related]
24. 6-Arylamino-7-chloro-quinazoline-5,8-diones as novel cytotoxic and DNA topoisomerase inhibitory agents.
Park HJ; Kim YS; Kim JS; Lee EJ; Yi YJ; Hwang HJ; Suh ME; Ryu CK; Lee SK
Bioorg Med Chem Lett; 2004 Jul; 14(13):3385-8. PubMed ID: 15177438
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of new 1,5-diazaanthraquinones with cytotoxic activity.
Manzanaro S; Vicent MJ; Martín MJ; Salvador-Tormo N; Pérez JM; del Mar Blanco M; Avendaño C; Menéndez JC; de la Fuente JA
Bioorg Med Chem; 2004 Dec; 12(24):6505-15. PubMed ID: 15556767
[TBL] [Abstract][Full Text] [Related]
26. Indole, a core nucleus for potent inhibitors of tubulin polymerization.
Brancale A; Silvestri R
Med Res Rev; 2007 Mar; 27(2):209-38. PubMed ID: 16788980
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and structure-activity relationship studies of 4,11-diaminonaphtho[2,3-f]indole-5,10-diones.
Shchekotikhin AE; Glazunova VA; Luzikov YN; Buyanov VN; Susova OY; Shtil AA; Preobrazhenskaya MN
Bioorg Med Chem; 2006 Aug; 14(15):5241-51. PubMed ID: 16631372
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, inhibition of NO production and antiproliferative activities of some indole derivatives.
Sinicropi MS; Caruso A; Conforti F; Marrelli M; El Kashef H; Lancelot JC; Rault S; Statti GA; Menichini F
J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1148-53. PubMed ID: 19555184
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and in vitro cytotoxicity evaluation of novel naphthindolizinedione derivatives.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2007 Mar; 340(3):147-53. PubMed ID: 17315260
[TBL] [Abstract][Full Text] [Related]
30. 3-substituted 7-phenyl-pyrroloquinolinones show potent cytotoxic activity in human cancer cell lines.
Gasparotto V; Castagliuolo I; Ferlin MG
J Med Chem; 2007 Nov; 50(22):5509-13. PubMed ID: 17915851
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
Liu TZ; Chen CY; Yiin SJ; Chen CH; Cheng JT; Shih MK; Wang YS; Chern CL
Food Chem Toxicol; 2006 Feb; 44(2):227-35. PubMed ID: 16112786
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
33. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
[TBL] [Abstract][Full Text] [Related]
34. Two novel series of allocolchicinoids with modified seven membered B-rings: design, synthesis, inhibition of tubulin assembly and cytotoxicity.
Büttner F; Bergemann S; Guénard D; Gust R; Seitz G; Thoret S
Bioorg Med Chem; 2005 May; 13(10):3497-511. PubMed ID: 15848763
[TBL] [Abstract][Full Text] [Related]
35. MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps.
Kasibhatla S; Baichwal V; Cai SX; Roth B; Skvortsova I; Skvortsov S; Lukas P; English NM; Sirisoma N; Drewe J; Pervin A; Tseng B; Carlson RO; Pleiman CM
Cancer Res; 2007 Jun; 67(12):5865-71. PubMed ID: 17575155
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and antiproliferative activity of novel aminosubstituted benzothiopyranoisoindoles.
Christodoulou A; Kostakis IK; Kourafalos V; Pouli N; Marakos P; Trougakos IP; Tsitsilonis OE
Bioorg Med Chem Lett; 2011 May; 21(10):3110-2. PubMed ID: 21444205
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles.
Romagnoli R; Baraldi PG; Jung MK; Iaconinoto MA; Carrion MD; Remusat V; Preti D; Tabrizi MA; Francesca F; De Clercq E; Balzarini J; Hamel E
Bioorg Med Chem Lett; 2005 Sep; 15(18):4048-52. PubMed ID: 16005627
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
[TBL] [Abstract][Full Text] [Related]
39. Structural influence of indole C5-N-substitutents on the cytotoxicity of seco-duocarmycin analogs.
Choi T; Ma E
Arch Pharm Res; 2011 Mar; 34(3):357-67. PubMed ID: 21547666
[TBL] [Abstract][Full Text] [Related]
40. Substituted E-3-(2-Chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity.
Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Garaliene V; Farruggia G; Masotti L
Bioorg Med Chem; 2004 Mar; 12(5):1121-8. PubMed ID: 14980624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
